logo
Loading...
Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts
Medicine and HealthNATURE COMMUNICATIONS

Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts

R. Kundu, J. S. Narean, et al.

This groundbreaking study reveals how cross-reactive memory T cells could shield against SARS-CoV-2 infections. Analysis of immune responses from 52 COVID-19 household contacts uncovers a potential protective role of these T cells, especially those not targeting the spike protein. Discover insights from the research conducted by Rhia Kundu, Janakan Sam Narean, Lulu Wang, Joseph Fenn, Timesh Pillay, Nieves Derqui Fernandez, Emily Conibear, Aleksandra Koycheva, Megan Davies, Mica Tolosa-Wright, Seran Hakki, Robert Varro, Eimear McDermott, Sarah Hammett, Jessica Cutajar, Ryan S. Thwaites, Eleanor Parker, Carolina Rosadas, Myra McClure, Richard Tedder, Graham P. Taylor, Jake Dunning, and Ajit Lalvani.... show more
GeneralSummaryMetrics
Citation Metrics
Citations
350
Influential Citations
11
Reference Count
38
Citation by Year

Note: The citation metrics presented here have been sourced from Semantic Scholar and OpenAlex.

Related Publications

Explore these studies to deepen your understanding

Adjacent work that informs or extends this paper's methodology and findings.

Humoral and T Cell Immune Responses against SARS-CoV-2 after Primary and Homologous or Heterologous Booster Vaccinations and Breakthrough Infection: A Longitudinal Cohort Study in Malaysia
Biology

Humoral and T Cell Immune Responses against SARS-CoV-2 after Primary and Homologous or Heterologous Booster Vaccinations and Breakthrough Infection: A Longitudinal Cohort Study in Malaysia

J. Y. L. Fu, M. H. Pukhari, et al.

Effectiveness of BA.1-and BA.4/BA. 5-Containing Bivalent COVID-19 mRNA Vaccines Against Symptomatic SARS-CoV-2 Infection During the BA.5-Dominant Period in Japan
Medicine and Health

Effectiveness of BA.1-and BA.4/BA. 5-Containing Bivalent COVID-19 mRNA Vaccines Against Symptomatic SARS-CoV-2 Infection During the BA.5-Dominant Period in Japan

T. Arashiro, Y. Arima, et al.

An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants
Medicine and Health

An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants

W. Tai, S. Feng, et al.

COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in Wuhan
Medicine and Health

COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in Wuhan

H. Liang, X. Nian, et al.

Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 22+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny